As discussed above, expression of Zeb1 by cancer cells endows them with a more aggressive phenotype, including enhanced invasive capacities, therapeutic resistance, and stemness, resulting in poor clinical outcomes in a variety of human cancer types [110]. The gene discussed is ZEB1; the disease is cancer.